好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Molecular Markers and Targets in Neuro-oncology

Friday 04/16/10
01:00 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Integrated Neuroscience
Neuro-oncology
No CME available
Event Timeline
01:00 PM - 05:00 PM Abstract 001 - Radiation Sensitivity of Neural and Progenitor Stem Cells
01:00 PM - 05:00 PM Abstract 001 - Primary Central Nervous System EBV-Associated Lymphomatoid Granulomatosis: A Comprehensive Study of Three Cases
01:00 PM - 05:00 PM Abstract 002 - Role of Perfusion MR Imaging in Differentiating between Tumor-Progression and Pseudo-Progression in Recurrent Glioblastoma Multiforme
01:00 PM - 05:00 PM Abstract 002 - A Dramatic and Prolonged Response to Meningeal Gliomatosis
01:00 PM - 05:00 PM Abstract 003 - Sunitinib as an Antitumor Substance in Human Meningioma Cells
01:00 PM - 05:00 PM Abstract 003 - Lacosamide in Brain Tumor Patients
01:00 PM - 05:00 PM Abstract 004 - Efficacy of Bevacizumab Following Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor (VEGF-R) for Recurrent Glioblastoma (GBM)
01:00 PM - 05:00 PM Abstract 004 - Multi-Parametric Imaging and Immunohistochemistry Studies of the Effects of YC-1 on Rat C6 Glioma
01:00 PM - 05:00 PM Abstract 005 - Retrospective Review of Symptomatic Intracranial Hemorrhage (ICH) in Cancer Patients Treated with Bevacizumab; the Memorial Sloan-Kettering (MSK) Experience
01:00 PM - 05:00 PM Abstract 005 - Post-Therapy Non-Hemorrhagic T1 Hyperintensity on MRI in PCNSL Patients and Its Prognostic Implication
01:00 PM - 05:00 PM Abstract 006 - [[sup]18[/sup]F]FACBC and [[sup]18[/sup]F]FLT PET Imaging for Glioblastomas (GBM)
01:00 PM - 05:00 PM Abstract 006 - Late Relapse in Primary Central Nervous System Lymphoma
01:00 PM - 05:00 PM Abstract 007 - Neurological Outcome of Childhood Brain Tumor Survivors
Faculty Disclosures
Patrick Y. Wen, MD, FAAN Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prelude Therapeutics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VBI Vaccines . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation Bio. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines . Dr. Wen has received research support from Astra Zeneca . Dr. Wen has received research support from Black Diamond . Dr. Wen has received research support from Bristol Meyers Squibb . Dr. Wen has received research support from Celgene. Dr. Wen has received research support from Chimerix. Dr. Wen has received research support from Eli Lily . Dr. Wen has received research support from Erasca. Dr. Wen has received research support from Genentech/Roche . Dr. Wen has received research support from Kazia . Dr. Wen has received research support from MediciNova. Dr. Wen has received research support from Merck. Dr. Wen has received research support from Novartis. Dr. Wen has received research support from Nuvation Bio . Dr. Wen has received research support from Servier. Dr. Wen has received research support from Vascular Biogenics . Dr. Wen has received research support from VBI Vaccines . Dr. Wen has received publishing royalties from a publication relating to health care.
Warren P. Mason, MD, FAAN Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Ingelheim. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Therapeutics.
Santosh Kesari, MD, PhD, FAAN Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.
Tracy T. Batchelor, MD, MPH Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Lisa M. DeAngelis, MD, FAAN Dr. DeAngelis has received publishing royalties from a publication relating to health care.
No disclosure on file
Herbert B. Newton, MD No disclosure on file
Robert Cavaliere, MD No disclosure on file
Alexandros L. Georgiadis, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Lauren E. Abrey, MD No disclosure on file
Surasak Phuphanich, MD, FAAN No disclosure on file
Vineet Punia, MD Dr. Punia has nothing to disclose.
Glen H. Stevens, DO, PhD, FAAN The institution of Dr. Stevens has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. The institution of Dr. Stevens has received research support from National Cancer Institute.
Jeremy Rudnick, MD Dr. Rudnick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Rebecca Naor Rebecca Naor has nothing to disclose.
Lakshmi Nayak, MD Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceutical. An immediate family member of Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BraveBio. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kite/Gilead. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genmab. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curis. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Nayak has received publishing royalties from a publication relating to health care.
Andrew B. Lassman, MD, FAAN No disclosure on file
Christel Heidemans-Hazelaar, MD No disclosure on file
Christian Mawrin, MD No disclosure on file
Antonio M. Omuro, MD, FAAN Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo.
Sari Pietila, MD No disclosure on file
Charles J. Vecht, MD, PhD, FAAN No disclosure on file
Pamela Z. New, MD, FAAN No disclosure on file
Lizbeth Robles-Irizarry, MD No disclosure on file
Ronald G. Blasberg, MD No disclosure on file
Christian Grommes, MD Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Samuel Goldlust, MD No disclosure on file
Mustafa Khasraw, MD No disclosure on file
Craig S. Moore, PhD Dr. Moore has nothing to disclose.
Melissa S. Nicoletti No disclosure on file
Mackenzie A. Michell-Robinson, MSc Mackenzie A. Michell-Robinson has nothing to disclose.
Erin Sundermann Erin Sundermann has received personal compensation in the range of $0-$499 for serving as a Consultant for The University of Pittsburgh. Erin Sundermann has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for University of Toronto. The institution of Erin Sundermann has received research support from California Department of Public Health. The institution of Erin Sundermann has received research support from National Institute of Aging. The institution of Erin Sundermann has received research support from Alzheimer's Association.
Jessica Rowe No disclosure on file
Hakan Akgun No disclosure on file
Seref Demirkaya, PhD No disclosure on file
Mehmet Yucel, MD No disclosure on file
Venkatraman Karthikeayan, MD No disclosure on file
Kesavamurthy Bhanu, MD No disclosure on file